Aberrant Methylation of PCDH10 Predicts Worse Biochemical Recurrence-Free Survival in Patients with Prostate Cancer After Radical Prostatectomy

BACKGROUND: Prostate cancer is a common malignancy in men, and inevitably some patients experience biochemical recurrence after radical prostatectomy. To date, there are no reliable predictors for prostate cancer recurrence, and novel predictors are urgently needed. PCDH10 (protocadherin-10) is a no...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li, Xie, Pei-Gen, Lin, Ying-Li, Ma, Jian-Guo, Li, Wen-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2014
Materias:
Lab/In Vitro Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136935/
https://www.ncbi.nlm.nih.gov/pubmed/25086586
http://dx.doi.org/10.12659/MSM.891241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136935/
https://www.ncbi.nlm.nih.gov/pubmed/25086586
http://dx.doi.org/10.12659/MSM.891241

Ejemplares similares